Table 1 Comparison of positivity rates, demographic characteristics and co-infection patterns in S. aureus-associated patients before and during the COVID-19 pandemic.
Variables | Total | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
S. aureus-positives [No. (%)] | 399 (6.7) | 97 (6.4) | 102 (6.3) | 56 (6.4) | 78 (7.5) | 66 (7.4) |
Male patients [No. (%)] | 233 (58.4) | 52 (53.6) | 66 (64.7) | 37 (66.1) | 42 (53.8) | 36 (54.5) |
Age (months) | 2 (1–9) | 2 (1–7) | 3 (1–15.25) | 2.5 (1–9.75) | 2 (1–7) | 2 (1–8.25) |
Respiratory co-infections [No. (%)] | Â | Â | Â | Â | Â | Â |
 S. pneumoniae | 14 (3.5) | 4 (4.1) | 4 (3.9) | 2 (3.6) | 3 (3.8) | 1 (1.5) |
 H. influenzae | 30 (7.5) | 6 (6.2) | 17 (16.7)a | 3 (5.4)b | 1 (1.3)b | 3 (4.5)b |
 M. catarrhalis | 36 (9.0) | 8 (8.2) | 13 (12.7) | 3 (5.4) | 7 (9.0) | 5 (7.6) |
 M. pneumoniae | 39 (19.3) | 8 (17.0) | 16 (21.9) | 6 (20.0) | 4 (12.1) | 5 (26.3) |
 IVA | 2 (0.5) | 0 (0.0) | 2 (2.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
 IVB | 2 (0.5) | 0 (0.0) | 0 (0.0) | 1 (1.8) | 1 (1.3) | 0 (0.0) |
 PIV | 10 (2.7) | 3 (3.2) | 1 (1.0) | 3 (5.5) | 3 (3.9) | 0 (0.0) |
 RSV | 44 (11.4) | 11 (11.7) | 10 (9.9) | 6 (10.9) | 14 (18.2) | 3 (5.0) |
 ADV | 3 (0.8) | 1 (1.1) | 0 (0.0) | 1 (1.8) | 0 (0.0) | 1 (1.7) |
